Cargando…
E2F4 regulatory program predicts patient survival prognosis in breast cancer
INTRODUCTION: Genetic and molecular signatures have been incorporated into cancer prognosis prediction and treatment decisions with good success over the past decade. Clinically, these signatures are usually used in early-stage cancers to evaluate whether they require adjuvant therapy following surg...
Autores principales: | Khaleel, Sari S, Andrews, Erik H, Ung, Matthew, DiRenzo, James, Cheng, Chao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4303196/ https://www.ncbi.nlm.nih.gov/pubmed/25440089 http://dx.doi.org/10.1186/s13058-014-0486-7 |
Ejemplares similares
-
Contextual Refinement of Regulatory Targets Reveals Effects on Breast Cancer Prognosis of the Regulome
por: Andrews, Erik, et al.
Publicado: (2017) -
The E2F4 prognostic signature predicts pathological response to neoadjuvant chemotherapy in breast cancer patients
por: Mark, Kenneth M. K., et al.
Publicado: (2017) -
Biodiversity is decimated by the cascading effects of the amphibian-killing chytrid fungus
por: Zipkin, Elise F., et al.
Publicado: (2022) -
Integrative analysis of survival-associated gene sets in breast cancer
por: Varn, Frederick S, et al.
Publicado: (2015) -
Mammary epithelial cells immortalized by over-expression of the catalytic subunit of human telomerase may represent a model for mammary epithelial differentiation
por: DiRenzo, J, et al.
Publicado: (2000)